Prognostic indicators in diffuse large-cell (histiocytic) lymphoma
- 1 April 1986
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 12 (4) , 593-601
- https://doi.org/10.1016/0360-3016(86)90068-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The clinical significance of the morphological subdivision of diffuse "histiocytic" lymphoma: a study of 162 patients treated by the Southwest Oncology GroupBlood, 1982
- Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP)Cancer, 1982
- The usefulness of the lukes-collins classification in identifying subsets of diffuse histiocytic lymphoma responsive to chemotherapyCancer, 1982
- Combination Chemotherapy of Advanced Diffuse Histiocytic Lymphoma with the Six-Drug COP-BLAM RegimenAnnals of Internal Medicine, 1982
- Treatment of advanced diffuse histiocytic lymphoma: An analysis of prognostic variablesCancer, 1982
- Factors predicting long-term survival in diffuse mixed, histiocytic, or undifferentiated lymphomaBlood, 1981
- Clinical usefulness and reproducibility of histologic subclassification of advanced diffuse histiocytic lymphomaThe American Journal of Medicine, 1979
- Combination chemotherapy of diffuse histiocytic lymphoma with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP)Cancer, 1978
- Non-hodgkin's lymphomas.A clinicopathologic study comparing two classificationsCancer, 1978
- Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapyThe American Journal of Medicine, 1977